Home/Filings/4/0000950170-25-089040
4//SEC Filing

Waxman Alan 4

Accession 0000950170-25-089040

CIK 0002019410other

Filed

Jun 22, 8:00 PM ET

Accepted

Jun 23, 4:45 PM ET

Size

49.2 KB

Accession

0000950170-25-089040

Insider Transaction Report

Form 4
Period: 2025-06-20
Transactions
  • Conversion

    Common Stock

    2025-06-20+3,493,7893,493,789 total(indirect: By LLC)
  • Exercise of In-Money

    Common Stock

    2025-06-20+1,711,1135,687,176 total(indirect: By LLC)
  • Conversion

    Common Stock

    2025-06-20+478,779478,779 total(indirect: Held by Sixth Street Specialty Lending, Inc.)
  • Conversion

    Common Stock

    2025-06-20+10,103,17510,103,175 total(indirect: By LLC)
  • Exercise of In-Money

    Common Stock

    2025-06-20+2,255,0483,976,063 total(indirect: By LLC)
  • Exercise of In-Money

    Common Stock

    2025-06-20+90,0591,219,271 total(indirect: Held by Sixth Street Specialty Lending, Inc.)
  • Conversion

    Series C Preferred Stock

    2025-06-206,884,0580 total(indirect: By LLC)
    Common Stock (1,721,015 underlying)
  • Exercise of In-Money

    2020 Warrants

    2025-06-2010,829,8230 total(indirect: By LLC)
    Exp: 2027-04-02Common Stock (1,711,113 underlying)
  • Conversion

    Series C Preferred Stock

    2025-06-2015,527,9510 total(indirect: By LLC)
    Common Stock (3,881,988 underlying)
  • Conversion

    Series D Preferred Stock

    2025-06-2023,574,0730 total(indirect: By LLC)
    Common Stock (10,103,175 underlying)
  • Exercise of In-Money

    2020 Warrants

    2025-06-20569,9910 total(indirect: Held by Sixth Street Specialty Lending, Inc.)
    Exp: 2027-04-02Common Stock (90,059 underlying)
  • Conversion

    Series C Preferred Stock

    2025-06-2013,975,1550 total(indirect: By LLC)
    Common Stock (3,493,789 underlying)
  • Exercise of In-Money

    2018 Warrants

    2025-06-2013,009,8920 total(indirect: By LLC)
    Exp: 2025-09-20Common Stock (2,255,048 underlying)
  • Conversion

    Common Stock

    2025-06-20+1,721,0151,721,015 total(indirect: By LLC)
  • Conversion

    Common Stock

    2025-06-20+3,881,9883,881,988 total(indirect: By LLC)
  • Conversion

    Common Stock

    2025-06-20+531,7461,010,525 total(indirect: Held by Sixth Street Specialty Lending, Inc.)
  • Exercise of In-Money

    Common Stock

    2025-06-20+118,6871,129,212 total(indirect: Held by Sixth Street Specialty Lending, Inc.)
  • Conversion

    Series D Preferred Stock

    2025-06-201,240,7400 total(indirect: Held by Sixth Street Specialty Lending, Inc.)
    Common Stock (531,746 underlying)
  • Exercise of In-Money

    2018 Warrants

    2025-06-20684,7310 total(indirect: Held by Sixth Street Specialty Lending, Inc.)
    Exp: 2025-09-20Common Stock (118,687 underlying)
  • Conversion

    Series C Preferred Stock

    2025-06-201,915,1140 total(indirect: Held by Sixth Street Specialty Lending, Inc.)
    Common Stock (478,779 underlying)
Transactions
  • Conversion

    Common Stock

    2025-06-20+3,493,7893,493,789 total(indirect: By LLC)
  • Exercise of In-Money

    Common Stock

    2025-06-20+118,6871,129,212 total(indirect: Held by Sixth Street Specialty Lending, Inc.)
  • Conversion

    Series C Preferred Stock

    2025-06-206,884,0580 total(indirect: By LLC)
    Common Stock (1,721,015 underlying)
  • Conversion

    Series C Preferred Stock

    2025-06-2015,527,9510 total(indirect: By LLC)
    Common Stock (3,881,988 underlying)
  • Conversion

    Series C Preferred Stock

    2025-06-201,915,1140 total(indirect: Held by Sixth Street Specialty Lending, Inc.)
    Common Stock (478,779 underlying)
  • Conversion

    Series D Preferred Stock

    2025-06-201,240,7400 total(indirect: Held by Sixth Street Specialty Lending, Inc.)
    Common Stock (531,746 underlying)
  • Exercise of In-Money

    2018 Warrants

    2025-06-2013,009,8920 total(indirect: By LLC)
    Exp: 2025-09-20Common Stock (2,255,048 underlying)
  • Conversion

    Common Stock

    2025-06-20+1,721,0151,721,015 total(indirect: By LLC)
  • Conversion

    Common Stock

    2025-06-20+531,7461,010,525 total(indirect: Held by Sixth Street Specialty Lending, Inc.)
  • Exercise of In-Money

    Common Stock

    2025-06-20+2,255,0483,976,063 total(indirect: By LLC)
  • Exercise of In-Money

    Common Stock

    2025-06-20+90,0591,219,271 total(indirect: Held by Sixth Street Specialty Lending, Inc.)
  • Conversion

    Series C Preferred Stock

    2025-06-2013,975,1550 total(indirect: By LLC)
    Common Stock (3,493,789 underlying)
  • Conversion

    Series D Preferred Stock

    2025-06-2023,574,0730 total(indirect: By LLC)
    Common Stock (10,103,175 underlying)
  • Exercise of In-Money

    2020 Warrants

    2025-06-2010,829,8230 total(indirect: By LLC)
    Exp: 2027-04-02Common Stock (1,711,113 underlying)
  • Exercise of In-Money

    2020 Warrants

    2025-06-20569,9910 total(indirect: Held by Sixth Street Specialty Lending, Inc.)
    Exp: 2027-04-02Common Stock (90,059 underlying)
  • Conversion

    Common Stock

    2025-06-20+3,881,9883,881,988 total(indirect: By LLC)
  • Conversion

    Common Stock

    2025-06-20+478,779478,779 total(indirect: Held by Sixth Street Specialty Lending, Inc.)
  • Conversion

    Common Stock

    2025-06-20+10,103,17510,103,175 total(indirect: By LLC)
  • Exercise of In-Money

    Common Stock

    2025-06-20+1,711,1135,687,176 total(indirect: By LLC)
  • Exercise of In-Money

    2018 Warrants

    2025-06-20684,7310 total(indirect: Held by Sixth Street Specialty Lending, Inc.)
    Exp: 2025-09-20Common Stock (118,687 underlying)
Footnotes (7)
  • [F1]Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date.
  • [F2]Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date.
  • [F3]The 2018 warrants were exercisable at the option of the holder into shares of Series C Preferred Stock of the Issuer at an exercise price of $1.61 per share and into Common Stock at an exercise price of $6.44 per share. Immediately prior to and in connection with the closing of the Issuer's IPO, the 2018 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO.
  • [F4]The 2020 warrants were exercisable into Series C preferred stock at a price of $1.93 per share and into Common Stock at a price of $7.73 per share. Immediately prior to and in connection with the closing of the Issuer's IPO the 2020 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO.
  • [F5]TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company ("Sub-Fund HoldCo"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company ("TAO SPV"), and Empire SPV GP, LLC, a Delaware limited liability company ("Empire SPV"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC.
  • [F6]TSSP Holdco Management, LLC, a Delaware limited liability company ("Holdco Management"), manages Sixth Street Specialty Lending Advisers Holdings, LLC, a Delaware limited liability company ("Adviser Holdings"). The business and affairs of Sixth Street Specialty Lending Advisers, LLC, a Delaware limited liability company ("Adviser"), are managed by Adviser Holdings, the sole member of Adviser. Sixth Street Specialty Lending, Inc. is managed by Adviser.
  • [F7]Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein.

Documents

1 file

Issuer

Caris Life Sciences, Inc.

CIK 0002019410

Entity typeother

Related Parties

1
  • filerCIK 0001515132

Filing Metadata

Form type
4
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 4:45 PM ET
Size
49.2 KB